Global Smoking Cessation Market Analysis & Forecasts Point Out Chantix As Pfizer's Blockbuster Medicine
Date: 7th August 2007
The global quit smoking market analysis and forecast report that examines the smoking cessation market in various countries such as UK, Spain, Australia, US, Japan, Canada et al reveals that the Pfizer's anti-smoking drug Chantix is slated to be the markets` blockbuster medicine. Alongside the report also throws light on issues such as whether the sales of the anti-smoking medication Zyban would be affected by the popularity of chantix/champix.
Moreover, as far as Chantix is concerned, it is known that the report delves deeply into the present as well as future market dominance by chantix/champix. In addition to that, the market report that concerns the worldwide pharmaceutical industry deals with quit smoking treatments other than chantix/zyban and almost each and every specific detail on the market that is related to quit smoking or quit smoking medications.